statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Flagship Appoints Amy O'Shea as CEO-Partner and Chief Executive Officer of Invaio Sciences Flagship Appoints Amy O'Shea as CEO-Partner and Chief Executive Officer of Invaio Sciences PR Newswire...

Flagship Appoints Amy O'Shea as CEO-Partner and Chief Executive Officer of Invaio Sciences

Piper Sandler reaffirmed their overweight rating on shares of Omega Therapeutics (NASDAQ:OMGA - Free Report) in a research note issued to investors on Wednesday, Benzinga reports. The brokerage...

Piper Sandler Reaffirms Overweight Rating for Omega Therapeutics (NASDAQ:OMGA)

Omega Therapeutics, Inc. (NASDAQ:OMGA - Free Report) - Equities researchers at Chardan Capital increased their FY2024 EPS estimates for Omega Therapeutics in a research report issued to clients and...

FY2024 EPS Estimates for Omega Therapeutics, Inc. Lifted by Chardan Capital (NASDAQ:OMGA)

Omega Therapeutics (NASDAQ:OMGA - Free Report) had its target price reduced by Chardan Capital from $12.00 to $7.00 in a research report sent to investors on Monday, Benzinga reports. They currently...

Chardan Capital Cuts Omega Therapeutics (NASDAQ:OMGA) Price Target to $7.00

For the last three days, A.I.dvisor has detected that OMGA's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

Omega Therapeutics (OMGA, $3.2) Aroon Indicator entered a Downtrend on April 01, 2024.

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Omega Therapeutics price target lowered by $5 at Chardan, here's why

Omega Therapeutics And Novo Nordisk Collaboration: A Cautious 'Buy...

Omega Therapeutics And Novo Nordisk Collaboration: A Cautious 'Buy'

InvestorPlace - Stock Market News, Stock Advice & Trading Tips
OMGA stock results show that Omega Therapeutics beat analyst estimates for earnings per share and beat on revenue for the fourth quarter...

OMGA Stock Earnings: Omega Therapeutics Beats EPS, Beats Revenue for Q4 2023

Omega Therapeutics, Inc. (OMGA) came out with a quarterly loss of $0.37 per share versus the Zacks Consensus Estimate of a loss of $0.46. This compares to loss of $0.64 per share a year ago. These...

Omega Therapeutics, Inc. (OMGA) Reports Q4 Loss, Tops Revenue Estimates

Omega Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of DNA-sequence-targeting and mRNA-encoded therapeutics. It offers its product under the OMEGA platform. The company was founded by Noubar B. Afeyan and David Berry on July 13, 2016 and is headquartered in Cambridge, MA.

Volume	250,249.00
52-Wk High	$10.09
52-Wk Low	$1.30

OMGA Omega Therapeutics Inc

About

Feed

News

Earnings

Fundamentals